Royalty Pharma Sub-Manager, LLC

13F Portfolio Filings

Most recent 13F
Q2 2026
Location
New York, NY
CIK
0002081668
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q2 2026 4 241,917 CYTK, ZBIO, KAILERA THERAPEUTICS, BHVN RESTATEMENT 8/21/2026 000208166826000018
Q1 2026 4 172,764 CYTK, ZBIO, BCRX, BHVN RESTATEMENT 8/21/2026 000208166826000017
Q4 2025 4 171,312 CYTK, ZBIO, BHVN, BCRX RESTATEMENT 8/21/2026 000208166826000015
Additional filings from Royalty Pharma Sub-Manager, LLC that have since been restated